The free online learning platform and associated national training pilot, made possible with support from the Robert Wood Johnson Foundation, is designed to equip physicians and other professionals on the...
Researchers have found that multiple myeloma patients with a genetic variation in the gene FOPNL die on average 1-3 years sooner than patients without it. The finding was identified with...
The Ï㽶ÊÓƵ of Utah’s Center for Clinical and Translational Science (CCTS) and Program in Personalized Health has awarded grants to eight interdisciplinary projects to advance research and practices leading toward...
Genomics England announced that it will be using technology co-developed in a partnership between the Ï㽶ÊÓƵ of Utah and Omicia to interpret the DNA of Britons as part of the...
U.S. News & World Report has ranked Intermountain Healthcare’s Primary Children’s Hospital in Salt Lake City, Utah, in seven specialties in the new 2015-16 Best Children’s Hospitals rankings.
The PAM50 breast cancer signature developed at the Ï㽶ÊÓƵ of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City.
Cells with a mutation in the gene called K-Ras found mostly in cancers with the worst prognoses behave in ways that subvert the normal mechanisms of cell death
